675
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Protective effects of Naoxintong Capsule on rats with blood stasis syndrome

, , , , , , , & show all
Pages 1077-1086 | Received 12 May 2020, Accepted 03 Sep 2020, Published online: 14 Sep 2020

References

  • Luepker RV, Lakshminarayan K, Detels R, et al. Oxford textbook of public health. Vol. the practice of public health. Oxford: Oxford University Press; 2009. (Cardiovascular and cerebrovascular diseases).
  • Dan B, Clavey S, Stoger E, et al. Materia medica: chinese herbal medicine. Seattle (WA): Eastland Press; 2004.
  • Bi C, Li PL, Liao Y, et al. Pharmacodynamic effects of Dan-hong injection in rats with blood stasis syndrome. Biomed Pharmacother. 2019;118(2019):109187.
  • Zhao X, Zhang Y, Meng X, et al. Effect of a traditional Chinese medicine preparation Xindi soft capsule on rat model of acute blood stasis: a urinary metabonomics study based on liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;873(2):151–158.
  • Liu H, Zhang WJ, Long CF, et al. Protective effects of traditional Chinese herbal formula Compound Xueshuantong Capsule (CXC) on rats with blood circulation disorders. Biotechnol Biotechnol Equip. 2017;31(4):1–9.
  • Liu H, Peng YY, Liang FY, et al. Protective effects of traditional Chinese medicine formula NaoShuanTong Capsule on haemorheology and cerebral energy metabolism disorders in rats with blood stasis. Biotechnol Biotechnol Equip. 2014;28(1):140–146.
  • Wang J, Chu FY, Li J, et al. Study on syndrome element characteristics and its correlation with coronary angiography in 324 patients with coronary heart disease. Chin J Integr Med. 2008;14(4):274–280.
  • Li HX, Han SY, Wang XW, et al. Effect of the carthamins yellow from Carthamus tinctorius L. on hemorheological disorders of blood stasis in rats. Food Chem Toxicol. 2009;47(8):1797–1802.
  • Liu P, Shu-Lan SU, Zhou W, et al. Evaluating Effects of Xiangfu Siwu Decoction and Siwu Decoction on Hemorheological Indexes and Ovarian Function in Rat Model of Acute Blood Stasis. Chin J Integr Med. 2010;16(8):124–127.
  • Wang S, Liu Y. Activating blood circulation to dissipate blood stasis effect and anti-hypoxia effect of Salviae Miltiorrhizae Liguspyragine Hydrochloride and Glucose injection. Mod J Integr Tradit Chin West Med. 2014;23:358–362.
  • Zhang JH, Huang XL, Huang HB, et al. Effects of compound Xueshuantong dripping-pill on the hemorrheology in blood stasis rats and the clotting-time of mice. Chin Pharm J. 2004;39(5):350–352.
  • Thrall G, Lip GYH. Haemoconcentration and the hypercoagulable state associated with mental stress. Thromb Res. 2005;115(3):171–173.
  • He Y, Wan H, Du Y, et al. Protective effect of Danhong injection on cerebral ischemia-reperfusion injury in rats. J Ethnopharmacol. 2012;144(2):387–394.
  • Wang PR, Wang JS, Zhang C, et al. Huang-Lian-Jie-Du-Decotion induced protective autophagy against the injury of cerebral ischemia/reperfusion via MAPK-mTOR signaling pathway. J Ethnopharmacol. 2013;149(1):270–280.
  • Li JH, Liu AJ, Li HQ, et al. Buyang huanwu decoction for healthcare: evidence-based theoretical interpretations of treating different diseases with the same method and target of vascularity. Evid Based Complement Alternat Med. 2014;2014:506783.
  • Guo Q, Zhong M, Mao X, et al. A systems biology perspective on the molecular mechanisms underlying the therapeutic effects of Buyang Huanwu Decoction on ischemic stroke. Rejuvenation Res. 2015;18(4):313–325.
  • Wan J, Song J, Xu Y. Clinical effect of Naoxintong Capsule on treatment of lipid and carotid atherosclerosis plaques in patients with cerebral infarction. World Chin Med. 2012;7(4):299–301.
  • Zheng Y, Zhang Y, Li C, et al. Antithrombotic treatment with Naoxintong Capsule for the patients underg oing percutaneous coronary intervention: a clinical research on 27 cases. J Tradit Chin Med. 2012;53(4):299–303.
  • Zhao J, Zhu H, Wang S, et al. Naoxintong protects against atherosclerosis through lipid-lowering and inhibiting maturation of dendritic cells in LDL receptor knockout mice fed a high-fat diet. Curr Pharm Des. 2013; 19(33):5891–5896.
  • Zhong XN, Wang HH, Lu ZQ, et al. Effects of Naoxintong on atherosclerosis and inducible nitric oxide synthase expression in atherosclerotic rabbit. Chinese Med J. 2013; 126(6):1166–1170.
  • Zhang WJ, Su WW, Li PB, et al. Naoxintong Capsule inhibits the development of cardiovascular pathological changes in Bama Minipig through improving gut microbiota. Front Pharmacol. 2019;10(10):1128.
  • Zhang H, Wang WR, Lin R, et al. Buyang Huanwu decoction ameliorates coronary heart disease with Qi deficiency and blood stasis syndrome by reducing CRP and CD40 in rats. J Ethnopharmacol. 2010;130(1):98–102.
  • Wang QY, Guo H, Zhao BC, et al. Effects of Naoxintong Capsule on permeability of the blood brain barrier in focal cerebral ischemia—reperfusion in rats. Chin J Clin Pharmacol. 2016;32(10):890–893.
  • Song SH, Kim JH, Lee JH, et al. Elevated blood viscosity is associated with cerebral small vessel disease in patients with acute ischemic stroke. BMC Neurol. 2017;17(1):20.
  • Wen Z, Yao W, Xie L, et al. Influence of neuraminidase on the characteristics of microrheology of red blood cells. Clin Hemorheol Microcirc. 2000;23(1):51–57.
  • Li XC, Zhao DM, Xiang AL. Effects of Naoxintong Capsules on hemorheology and coagulation function in patients with acute cerebral infarction. China Pharm. 2014;28(1):2623–2625.
  • Chan KC, Yin MC, Chao WJ. Effect of diallyl trisulfide-rich garlic oil on blood coagulation and plasma activity of anticoagulation factors in rats. Food Chem Toxicol. 2007;45(3):502–507.
  • Ahmed M, Chowdhury NA, Sofdar G, et al. High fibrinogen level is an independent predictor of presence and severity of coronary artery disease. Cardiovasc J. 2014;7(1):4–10.
  • de Moerloose P, Boehlen F, Neerman-Arbez M. Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb Hemost. 2010;36(1):7–17.
  • Lieming XU. Resolving blood stasis to improve liver microcirculation and treat chronic liver diseases. J. Clin. Hepatol. 2013; 29(4):257–263.
  • Yang X, Li Y, Sun L. NaoXinTong enhances atorvastatin-induced plaque stability while ameliorating atorvastatin-induced hepatic inflammation. J Cardiovasc Pharm. 2016; 69(1):55–64.
  • Parameshwaran K, Irwin MH, Steliou K, et al. D-Galactose effectiveness in modeling aging and therapeutic antioxidant treatment in mice. Rejuvenation Res. 2010;13(6):729–735.
  • Zhang F, Huang B, Zhao Y, et al. BNC Protects H9c2 cardiomyoblasts from H 2 O 2 -induced oxidative injury through ERK1/2 signaling pathway . Evid Based Complement Alternat Med. 2013;2013:802784 [2013 Sep 09];
  • Ma XJ, Yin HJ, Chen KJ. Research progress of correlation between blood-stasis syndrome and inflammation. Chin J Integrated Tradit Western Med. 2007; 27(7):669–672.
  • Zhu H, Lin X, Zheng P, et al. Inflammatory cytokine levels in patients with periodontitis and/or coronary heart disease. Int J Clin Exp Pathol. 2015; 8(2):2214–2220.
  • Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000; 148(2):209–214.
  • Palur Ramakrishnan AV, Varghese TP, Vanapalli S, et al. Platelet activating factor: a potential biomarker in acute coronary syndrome? Cardiovasc Ther. 2017;35(1):64–70.
  • Luo LJ, Zhu MZ, Wang H, et al. Research on correlation between sublingual venae characteristic of blood stasis syndrome and serum PAF and vegf expressions in patients with ischemic stroke. Liaoning J Tradit Chin Med. 2018; 45(2):248–251.
  • Paraskevi D, Tzortzis N, Elizabeth F, et al. Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy. Curr Heart Fail Rep. 2013; 10(2):122–129.
  • Li P, Su W, Yun S, et al. Toward a scientific understanding of the effectiveness, material basis and prescription compatibility of a Chinese herbal formula Dan-hong injection. Sci Rep. 2017;7:46266.
  • Chen DK, Zhang HQ, Zhang JH. Intervening effect of Naoxintong on anti-platelet treatment with aspirin. Chin J Integr Med. 2008;28(9):843–846.
  • Chen H, Wu XY, Wu HX, et al. A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism. Chin J Integr Med. 2014;20(12):894–902.
  • Zhao J, Nagle DG, Zhou YD, et al. Network Pharmacology in the study of TCM formulae. In: Zhang WD, editor. Systems biology and its application in TCM formulas research. Vol. 4. New York: Academic Press; 2018. p. 69–95.
  • Liang QE, Cai YF, Chen RX, et al. The effect of Naoxintong Capsule in the treatment of patients with cerebral infarction and carotid atherosclerosis: a systematic review and meta-analysis of randomized trials. Evid Based Complement Alternat Med. 2018;2018:1–9.
  • Liu LT. Chinese Experts Consensus on Clinical Application of Naoxintong Capsule [脑心通胶囊]. Chin J Integr Med. 2018;24(3):232–236.